Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
Adolescent acne therapies benefit younger children
December 2nd 2020A recent paper suggests younger children with acne vulgaris should be treated the same as adolescents. This includes utilizing combination therapies that may consist of topic retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics.
Strategies for choosing and using neuromodulators
November 20th 2020All safe and effective, the four neuromodulators with cosmetic indications have nuanced differences worth considering. Seth Matarasso, M.D., explains the benefits of these cosmetic neuromodulators, and reveals how to know when to choose the right one.
Robotic-controlled laser advances body contouring
November 18th 2020A novel robotic-controlled 1064-nm laser brings efficiency and precision to body contouring. The clinical trial supporting FDA clearance of the device showed its effectiveness based on blinded photographic assessments, ultrasound measurements and circumferential assessments.
Case series draws attention to phenotype of acne scarring
September 10th 2020A retrospective review of patients seen in an academic dermatology clinic over a one-year period identified 20 individuals with nasal papules in association with acne, which are thought to represent scarring sequelae. The condition is underrecognized, researchers say and requires further research to better understand.
COVID-19 safety guidelines provide protocols to protect staff, patients
August 27th 2020Safety guidelines from the European Academy of Facial Plastic Surgery Aesthetic Medicine Focus Group describe protocols for protecting clinic staff and patients from COVID-19. Recommendations include procedures before, during and after a patient visit, as well as necessary forms.
Phenotypes inform management options
August 20th 2020Many patients with rosacea have features that overlap more than one subtype of the condition. A recent publication serves as a compliment to the classification guide with the intention of guiding treatment and management options based on individual patient features.
Specialized skincare regimen improves rosacea symptoms
August 14th 2020Effects of a specialized skincare regimen for sensitive and redness-prone skin were investigated in an eight-week, prospective, controlled clinical trial enrolling 60 patients with rosacea. The intervention was associated with improvements in objectively measured erythema, rosacea symptoms, and health-related quality of life.
Collaboration makes progresses standards for implementing AI
August 11th 2020The International Skin Imaging Collaboration is an academic and industry partnership designed to facilitate the clinical application of digital skin imaging, with an initial focus on melanoma. The group is developing standards for dermatologic imaging and building a public archive of clinical and dermoscopic images for use in developing artificial intelligence diagnostic algorithms.
JAK-STAT inhibition an attractive target for atopic dermatitis drugs
June 15th 2020Jonathan H. Zippin, M.D., Ph.D., explains what existing drugs and investigational compounds that inhibit the JAK-STAT pathway are being investigated as treatment for atopic dermatitis, alopecia areata, vitiligo and psoriasis.